• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病中的肝胆功能障碍。

Hepatobiliary dysfunction in Type-2 diabetes mellitus.

作者信息

Manoria Piyush, Inamdar Sameer, Kumar Ravindra

机构信息

Department of Gastroenterology, Sri Aurobindo Medical College and PG Institute, Indore, Madhya Pradesh, India.

Department of Medicine, Sri Aurobindo Medical College and PG Institute, Indore, Madhya Pradesh, India.

出版信息

J Family Med Prim Care. 2017 Jul-Sep;6(3):563-567. doi: 10.4103/2249-4863.222018.

DOI:10.4103/2249-4863.222018
PMID:29417009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5787956/
Abstract

OBJECTIVE

Nonalcoholic fatty liver disease (NAFLD) and gallstones are frequently present in diabetics, but its exact prevalence is not well studied in India. We have done a prevalence study of hepatobiliary involvement in Type-2 diabetes mellitus (T2DM) and also studied the other risk factors of NAFLD.

MATERIALS AND METHODS

Two hundred diabetics and 200 controls underwent anthropometric measurements, abdominal ultrasonography, (USG) and biochemical tests at a tertiary care hospital. Univariate and multivariate logistic regression analyses were done.

RESULTS

One hundred and thirty (65%) diabetics and 47 (23.50%) controls were having USG evidence of fatty liver (odds ratio [OR] = 6.046, 95% confidence interval [CI]: 3.904-9.363 [ < 0.0001]). Raised liver enzymes were present in 42 (21%) diabetics and 16 (8%) controls [OR = 3.057, 95% CI: 1.654-5.648 [ < 0.004]). Gallstones were present in 32 (16%) diabetics and 10 (5%) controls (OR = 2.825; 95% CI: 1.850-4.315 < 0.0001). In addition, waist circumference (WC) and body mass index (BMI) were significantly more in diabetics, but lipid profile was not significantly deranged as compared to controls. Then, all patients with fatty liver were compared with patients with normal liver, and we found that fatty liver group was having raised BMI, WC, liver enzymes, and more dyslipidemia. Multivariate analysis was done which shows the presence of T2DM, elevated liver enzymes, obesity, and elevated WC as independent risk factors of fatty liver.

CONCLUSION

The prevalence of NAFLD and gallstones was higher in diabetics as compared to healthy population. In addition, the presence of T2DM, elevated liver enzymes, obesity, and elevated WC are independent predictors of NAFLD.

摘要

目的

非酒精性脂肪性肝病(NAFLD)和胆结石在糖尿病患者中很常见,但在印度其确切患病率尚未得到充分研究。我们对2型糖尿病(T2DM)患者的肝胆受累情况进行了患病率研究,并研究了NAFLD的其他危险因素。

材料与方法

在一家三级护理医院,对200名糖尿病患者和200名对照者进行了人体测量、腹部超声检查(USG)和生化检测。进行了单因素和多因素逻辑回归分析。

结果

130名(65%)糖尿病患者和47名(23.50%)对照者有超声检查显示脂肪肝的证据(比值比[OR]=6.046,95%置信区间[CI]:3.904 - 9.363[<0.0001])。42名(21%)糖尿病患者和16名(8%)对照者出现肝酶升高[OR = 3.057,95% CI:1.654 - 5.648[<0.004])。32名(16%)糖尿病患者和10名(5%)对照者有胆结石(OR = 2.825;95% CI:1.850 - 4.315<0.0001)。此外,糖尿病患者的腰围(WC)和体重指数(BMI)明显更高,但与对照者相比,血脂谱没有明显紊乱。然后,将所有脂肪肝患者与肝脏正常的患者进行比较,我们发现脂肪肝组的BMI、WC、肝酶升高,且血脂异常更多。进行了多因素分析,结果显示T2DM、肝酶升高、肥胖和WC升高是脂肪肝的独立危险因素。

结论

与健康人群相比,糖尿病患者中NAFLD和胆结石的患病率更高。此外,T2DM、肝酶升高、肥胖和WC升高是NAFLD 的独立预测因素。

相似文献

1
Hepatobiliary dysfunction in Type-2 diabetes mellitus.2型糖尿病中的肝胆功能障碍。
J Family Med Prim Care. 2017 Jul-Sep;6(3):563-567. doi: 10.4103/2249-4863.222018.
2
[Predictive value of body mass index combined with waist circumference for new-onset nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus].[体重指数联合腰围对2型糖尿病患者新发非酒精性脂肪性肝病的预测价值]
Nan Fang Yi Ke Da Xue Xue Bao. 2019 Nov 30;39(11):1293-1297. doi: 10.12122/j.issn.1673-4254.2019.11.05.
3
Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population.2型糖尿病人群中根据脂肪肝指数定义的非酒精性脂肪性肝病的患病率及预测因素
Clujul Med. 2016;89(1):82-8. doi: 10.15386/cjmed-544. Epub 2016 Jan 15.
4
Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.非酒精性脂肪性肝病与 2 型糖尿病的微血管并发症。
World J Gastroenterol. 2013 May 28;19(20):3134-42. doi: 10.3748/wjg.v19.i20.3134.
5
Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.甘油三酯葡萄糖指数及相关参数(甘油三酯葡萄糖-体重指数和甘油三酯葡萄糖-腰围)可识别超重/肥胖个体的非酒精性脂肪肝和肝纤维化。
Metab Syndr Relat Disord. 2021 Apr;19(3):167-173. doi: 10.1089/met.2020.0109. Epub 2020 Dec 1.
6
Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.非酒精性脂肪性肝病瘦型中国成年人的患病率、临床特征、危险因素和指标。
World J Gastroenterol. 2020 Apr 21;26(15):1792-1804. doi: 10.3748/wjg.v26.i15.1792.
7
What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?新指标相对脂肪量(RFM)在非酒精性脂肪性肝病(NAFLD)评估中的作用是什么?
Obes Surg. 2020 Feb;30(2):560-568. doi: 10.1007/s11695-019-04213-8.
8
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
9
Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus.尼日利亚II型糖尿病患者中的非酒精性脂肪性肝病
Pan Afr Med J. 2016 May 6;24:20. doi: 10.11604/pamj.2016.24.20.8181. eCollection 2016.
10
Nonalcoholic Fatty Liver Diseases among Recently Diagnosed Patients with Diabetes Mellitus and Risk Factors.近期诊断出的糖尿病患者中的非酒精性脂肪性肝病及其危险因素
Euroasian J Hepatogastroenterol. 2019 Jan-Jun;9(1):9-13. doi: 10.5005/jp-journals-10018-1288.

引用本文的文献

1
Liver Function-Related Indicators and Risk of Gallstone Diseases-A Multicenter Study and a Systematic Review and Meta-Analysis.肝功能相关指标与胆结石疾病风险——一项多中心研究及系统评价与荟萃分析
Gastroenterol Res Pract. 2024 Aug 24;2024:9097892. doi: 10.1155/2024/9097892. eCollection 2024.
2
The fat mass, estimated glomerular filtration rate, and chronic inflammation in type 2 diabetic patients.2 型糖尿病患者的体脂量、估计肾小球滤过率和慢性炎症。
J Clin Lab Anal. 2020 Jun;34(6):e23229. doi: 10.1002/jcla.23229. Epub 2020 Feb 11.
3
Prevalence and Association of Elevated Liver Transaminases in Type 2 Diabetes Mellitus Patients in Jeddah, Saudi Arabia.沙特阿拉伯吉达2型糖尿病患者肝转氨酶升高的患病率及相关性
Cureus. 2019 Jul 18;11(7):e5166. doi: 10.7759/cureus.5166.

本文引用的文献

1
The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes.全国2型糖尿病患者中NAFLD的负担及其特征
J Diabetes Res. 2016;2016:2931985. doi: 10.1155/2016/2931985. Epub 2016 Mar 30.
2
Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population.2型糖尿病人群中根据脂肪肝指数定义的非酒精性脂肪性肝病的患病率及预测因素
Clujul Med. 2016;89(1):82-8. doi: 10.15386/cjmed-544. Epub 2016 Jan 15.
3
Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India.印度哈里亚纳邦一个农村社区成年人群中非酒精性脂肪性肝病的患病率。
Indian J Public Health. 2016 Jan-Mar;60(1):26-33. doi: 10.4103/0019-557X.177295.
4
Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians?非酒精性脂肪性肝病与糖尿病和心血管疾病风险:对基层医疗医生而言什么是重要的?
J Family Med Prim Care. 2015 Jan-Mar;4(1):45-52. doi: 10.4103/2249-4863.152252.
5
Prevalence of gallstone disease in patients with type 2 diabetes and the risk factors in North Indian population: a case control study.北印度人群2型糖尿病患者胆结石疾病的患病率及危险因素:一项病例对照研究。
Indian J Gastroenterol. 2014 Nov;33(6):507-11. doi: 10.1007/s12664-014-0502-y. Epub 2014 Oct 7.
6
Role of diet and lifestyle changes in nonalcoholic fatty liver disease.饮食和生活方式改变在非酒精性脂肪性肝病中的作用。
World J Gastroenterol. 2014 Jul 28;20(28):9338-44. doi: 10.3748/wjg.v20.i28.9338.
7
Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).印度2型糖尿病患者非酒精性脂肪性肝病(NAFLD)患病率研究(SPRINT)。
J Assoc Physicians India. 2013 Jul;61(7):448-53.
8
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.系统评价:成人非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学和自然史。
Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30.
9
Diabetes mellitus and the risk of cholecystectomy.糖尿病与胆囊切除术风险。
Dig Liver Dis. 2011 Sep;43(9):742-7. doi: 10.1016/j.dld.2011.04.014. Epub 2011 May 26.
10
Nonalcoholic fatty liver disease in India - a lot done, yet more required!印度的非酒精性脂肪性肝病——已取得诸多进展,但仍需更多努力!
Indian J Gastroenterol. 2010 Nov;29(6):217-25. doi: 10.1007/s12664-010-0069-1. Epub 2010 Dec 30.